Navigation Links
New treatment boosts muscle function in myasthenia gravis
Date:8/13/2007

ST. PAUL, Minn. - A new type of treatment significantly reduces the severity of muscle weakness in myasthenia gravis (MG), giving hope for a new class of drugs to treat neurological disorders, according to a study published in the August 14, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

The drug, oral EN101antisense, inhibits the production of acetylcholine esterase, which is an important enzyme in the function of the neuromuscular junction, where nerves connect with muscles. Antisense is a synthetic, short segment of DNA that locks onto a strand of mRNA and blocks production of specific proteins.

This is the first time weve been able to show that antisense is effective and safe when taken orally for a neurological disease, said study author Zohar Argov, MD, with Hadassah Hebrew University Medical Center in Jerusalem and member of the American Academy of Neurology. Oral delivery of antisense has long been sought after since it is expected to improve patient compliance because daily injections wont be needed.

People with myasthenia gravis have increased fatigue and reduced strength in their voluntary muscles. Symptoms may also include a drooping eyelid, double vision, difficulty in swallowing, or slurred speech. Myasthenia gravis is believed to affect 20 out of every 100,000 people.

For the study, 16 people with myasthenia gravis were given daily doses of oral EN101 antisense for four days and monitored for one month. Four of the people later took the drug for a month. The study found that oral antisense reduced disease severity by an average of 46 percent, with patients experiencing improved muscle function, improved swallowing time and the disappearance of a drooping eyelid. Side effects reported during the study were dryness of eyes and mouth.

Experts say this discovery may have implications beyond myasthenia gravis. Oral antisense may become another mode of therapy in
'/>"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. Now umbilical cord helps in stroke treatment.
6. Now AIDS treatment comes dirt-cheap
7. Breast cancer treatment to be determined by gene test
8. Hemopurifier may revolutionise AIDS treatment
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...rding the treatment of AIDS/HIV infection that has...f a global research, AIDS still remains a puzzle t...nt of patients with HIV, or human immunodeficiency...very slowly.// Past research suggested that such ...
...s who make fewer visits to the dentists than their... the fact that smoking puts them more at risk from...holds true regardless of age, gender, race, ethnic..., location and insurance coverage. The study, repo...
...sity College of Medicine and Public Health had fou...esponding well to other treatments might be treate...NS) with significantly better results.// As an al...pproved the implantation of a vagus nerve stimulat...
...ch the oxygen-carrying protein in the red blood ce...ickled) shape that can disrupt circulation, leadin...es fatal complications. // "Sickle cell anemia is...disables children as they grow," according to Dr.W...
Other Medicine News:Health News:Study holds promise for new way to fight HIV 2Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2
(Date:7/23/2008)... with Protein Therapeutics that Modulate...DGE, Mass., July 23 /- Taligen Therap...porate growth plan with the,appointment of Abbie C...,establishment of its headquarters in Cambridge, M... co-founder of the company who remains president.,...
(Date:7/22/2008)...elopment Initiative bring MJFF,s,current active in... 20,2009, NEW YORK, July 22 /PRNewswire-USNewswi... transformative treatments and a cure for Parkinso...kinson,s Research has awarded,$2.7 million in tota...ds,were granted under MJFF,s Therapeutics Developm...
(Date:7/22/2008)...Apidra(R) Resulted in Significant, Reductions in A...Algorithm Used, ... from the "Adjust to,Target in Type 2 Diabetes: Co...nting for Adjustment of Mealtime Insulin Glulisine...ssociation,s (ADA) medical journal,Diabetes Care....
(Date:7/22/2008)... University Medical Center Based on Rose...he Test Differentiates Squamous From Non-Squamous ...quamous-Cell Carcinoma of the Lung With Sen...nt,This is the First CLIA Approved Test Which Leve...s for Accurate Diagnosis of Lung Cancer, REHOVOT,...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Angiotechs novel 5 FU Central Venous Catheter receives FDA 510 28k 29 clearance 4673 1Angiotechs novel 5 FU Central Venous Catheter receives FDA 510 28k 29 clearance 4673 2Angiotechs novel 5 FU Central Venous Catheter receives FDA 510 28k 29 clearance 4673 3Angiotechs novel 5 FU Central Venous Catheter receives FDA 510 28k 29 clearance 4673 4Angiotechs novel 5 FU Central Venous Catheter receives FDA 510 28k 29 clearance 4673 5Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers 1837 1Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers 1837 2Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 1Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 2Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 3Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 4Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 5Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 6Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 7Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 8Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 9Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 10Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 11Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 12Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 13Lotus Pharmaceuticals Inc Announces Fourth Quarter and Fiscal Year 2007 Results 17065 14ProGenTech Limited Appoints Executive Management Team 17063 1ProGenTech Limited Appoints Executive Management Team 17063 2
...h.D. Contributing Editor Harvard Medical School ...in African American patients has underscored the c...o the same medication. This concept holds true fo...any cases is due to individual genetic variations.... issues, valuable new laboratory tools have arrive...
...ng Editor The first human case of West Nile virus ...nsas in late June. The CDC has released few detai...5,s first documented incidence of the mosquito bor...e-stranded RNA flavivirus of about 11 kb. It prim...orses, and other vertebrates serving as incidental...
Other Medicine Technology:Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 2West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 4